Assertio Therapeutics Stock Filter Stocks by Fundamentals
| ASRT Stock | USD 0.98 0.03 2.97% |
Assertio Therapeutics fundamentals help investors to digest information that contributes to Assertio Therapeutics' financial success or failures. It also enables traders to predict the movement of Assertio Stock. The fundamental analysis module provides a way to measure Assertio Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Assertio Therapeutics stock.
Assertio | Shares Owned by Institutions |
Assertio Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Assertio Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Assertio Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Assertio Therapeutics' value.| Shares | Two Sigma Investments Llc | 2024-09-30 | 876 K | Amvescap Plc. | 2024-06-30 | 564.1 K | Bridgeway Capital Management, Llc | 2024-09-30 | 498.6 K | Susquehanna International Group, Llp | 2024-06-30 | 490.3 K | Empowered Funds, Llc | 2024-06-30 | 409.9 K | Jane Street Group Llc | 2024-06-30 | 406.6 K | Perritt Capital Management Inc. | 2024-09-30 | 390.1 K | Bank Of New York Mellon Corp | 2024-06-30 | 351.7 K | State Street Corp | 2024-06-30 | 339.3 K | Nantahala Capital Management, Llc | 2024-09-30 | 8.9 M | Vanguard Group Inc | 2024-09-30 | 4.5 M |
Assertio Fundamentals
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.0144 | ||||
| Profit Margin | (0.54) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 44.46 M | ||||
| Shares Outstanding | 95.34 M | ||||
| Shares Owned By Insiders | 2.47 % | ||||
| Shares Owned By Institutions | 38.46 % | ||||
| Number Of Shares Shorted | 6.26 M | ||||
| Price To Earning | 4.93 X | ||||
| Price To Book | 0.72 X | ||||
| Price To Sales | 0.74 X | ||||
| Revenue | 152.07 M | ||||
| Gross Profit | 138.29 M | ||||
| EBITDA | (222.45 M) | ||||
| Net Income | (331.94 M) | ||||
| Cash And Equivalents | 52.26 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 40.91 M | ||||
| Debt To Equity | 0.49 % | ||||
| Current Ratio | 1.00 X | ||||
| Book Value Per Share | 1.38 X | ||||
| Cash Flow From Operations | 49.6 M | ||||
| Short Ratio | 14.28 X | ||||
| Earnings Per Share | (4.94) X | ||||
| Price To Earnings To Growth | 1.22 X | ||||
| Target Price | 3.15 | ||||
| Number Of Employees | 53 | ||||
| Beta | 0.84 | ||||
| Market Capitalization | 81.8 M | ||||
| Total Asset | 286.42 M | ||||
| Retained Earnings | (651.54 M) | ||||
| Working Capital | 77.62 M | ||||
| Current Asset | 5.15 M | ||||
| Current Liabilities | 492.4 K | ||||
| Net Asset | 286.42 M |
About Assertio Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Assertio Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Assertio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Assertio Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.